GlassScriptPhysician profile
Lauren Archer
NPI 1194733766
$1,362.66
in general payments reported to CMS, 2019-2025
19 companies · $42.33 in 2025
The $42.33 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.25 · 2020: $219 · 2021: $245 · 2022: $478 · 2023: $265 · 2024: $48.42 · 2025: $42.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $328.97 | 2020-2023 | Natrelle Saline-Filled Breast Implants, Botox |
| Integra Lifesciences Corporation | $230.12 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Innovation Technologies INC | $176.13 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $90.14 | 2021-2022 | |
| Genzyme Corporation | $88.66 | 2019-2021 | |
| Revance Therapeutics, INC. | $72.85 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $53.68 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $42.65 | 2022 | |
| Janssen Biotech, INC. | $42.30 | 2022 | |
| Leo Pharma INC. | $39.91 | 2019-2020 | |
| Genentech USA, INC. | $36.97 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $23.44 | 2022 | |
| Merz North America, INC. | $22.99 | 2019 | |
| Allergan, INC. | $21.95 | 2021 | |
| Organogenesis INC. | $20.68 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.21 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.70 | 2020 | |
| Almirall LLC | $16.91 | 2022 | |
| Nabriva Therapeutics, Plc | $16.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.